Research
Here’s one reason why expensive stocks can continue to climb
MIT’s Andrew Lo On Adaptive Markets, Passive Indexing, And Systemic Shocks
It really is different this time for high-flying stock market
“How Much Brain Damage Do I Have?”
A biotech company focused on inherited diseases just raised $135 million from a bunch of Wall Street firms
A dangerous complacency: Why investors should prepare for a bull-market reversal
Anthony Hilton: We Really Need People Who Understand Tech
“Kill All The Quants”?: Models vs. Mania In The Current Financial Crisis
MIT Sloan School of Management launches new Healthcare Finance course; expands existing FinTech Ventures
Wall Street’s Next Frontier Is Hacking Into Emotions of Traders